Stock Price Quote

PANACEA BIOTEC LTD.

NSE : PANACEABIOBSE : 531349ISIN CODE : INE922B01023Industry : Pharmaceuticals & DrugsHouse : Soshil Kumar Jain
BSE233.45-0.5 (-0.21 %)
PREV CLOSE ( ) 233.95
OPEN PRICE ( ) 239.90
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 36470
TODAY'S LOW / HIGH ( )226.00 240.00
52 WK LOW / HIGH ( )119 265
NSE233.45-0.75 (-0.32 %)
PREV CLOSE( ) 234.20
OPEN PRICE ( ) 240.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 233.45 (54)
VOLUME 306141
TODAY'S LOW / HIGH( ) 230.60 240.35
52 WK LOW / HIGH ( )126.65 265
BSE NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1984
Management Info
Soshil Kumar Jain - Chairman Rajesh Jain - Managing Director
Registered Office

Address Ambala - Chandigarh Highway,,,
Lalru,
Punjab-140501

Phone 01762- 505900

Email investorgrievances@panaceabiotec.com

Website www.panacea-biotec.com

Registrars Details
Skyline Financial Services Pvt Ltd
D-153/A, 1st Floor,Okhla Industrial Area,Phase - I,New Delhi
Listing : BSE, NSE, MCX

NEWS

08Apr Clarification sought from Panacea Bio
The Exchange has sought clarification from Panacea Biotec Ltd on April 8..
06Apr Panacea Biotec, RDIF agree to produce
Panacea Biotec and the Russian Direct Investment Fund (RDIF, Russia's so..
05Apr Announcement under Regulation 30 (LOD
Panacea Biotec Ltd. ('PBL') is delighted to announce that the Russian Di..
05Oct Panacea Biotec gets warning letter fro
Panacea Biotec has received warning letter from US Food and Drug Adminis..
24Sep Panacea Biotec completes Phase 1/11 st
Panacea Biotec has successfully completed its Phase I/II study to evalua..
MORE

Financials

in Millions
QTR Dec 20 ANNUAL 20
Net Profit19-1530.8
Gross Profit 19.1 -789.300000000001
Operating Profit 104.4-313.5
Net Sales 690.21580.9
MORE

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Abbott India (BSE)
peergroup  15245.80 (1.32%)
M.Cap ( in Cr)32396.26
Pfizer (BSE)
peergroup  4797.80 (3.88%)
M.Cap ( in Cr)21948.85
Alkem Laboratories (BSE)
peergroup  2832.25 (4.66%)
M.Cap ( in Cr)33863.80
Sanofi India (BSE)
peergroup  8227.25 (1.04%)
M.Cap ( in Cr)18947.87
Procter&Gamble Healt (BSE)
peergroup  6362.40 (1.17%)
M.Cap ( in Cr)10561.19
MORE

Shareholding Pattern

PROMOTERS 73.59%
NON-INSTITUTION 25.02%
MUTUAL FUNDS/UTI 1.28%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%
MORE

Mf Holdings

Scheme NameHold(%)
ICICI Pru Pharma He...0.87
MORE

About Panacea Biotec Ltd.

Panacea Biotec Ltd. was incorporated in the year 1984. Its today's share price is 233.45. Its current market capitalisation stands at Rs 1429.9 Cr. In the latest quarter, company has reported Gross Sales of Rs. 4896.78 Cr and Total Income of Rs.5335.83 Cr. The company's management includes Vinod Goel, Shantanu Yeshwant Nalavadi, R L Narasimhan, N N Khamitkar, Mukul Gupta, Manjula Upadhyay, K M Lal, Bhupinder Singh, Ashwini Luthra, Ankesh Jain, Sandeep Jain, Rajesh Jain, Soshil Kumar Jain.

It is listed on the BSE with a BSE Code of 531349 , NSE with an NSE Symbol of PANACEABIO and ISIN of INE922B01023. It's Registered office is at Ambala - Chandigarh Highway,,Lalru-140501, Punjab. Their Registrars are ACC Ltd. It's auditors are SR Batliboi & Co LLP, Walker Chandiok & Co, Walker Chandiok & Co LLP

download beyond app
About Nirmal Bang About Nirmal Bang Awards & Accolades Careers at Nirmal Bang Contact Nirmal Bang
Product & Services Equity & Derivatives Trading Forex Trading Commodity Trading Institutional Broking Depository Services Loan Against Securities (LAS) Algo Trading
Equity Price Analysis Volume Analysis Index Analysis News Analysis Corporate Action India Market Other Market Share Market Holidays
Derivatives Updates Market Report Overview
IPO IPO Issues Performance News & Analysis
Commodities Market Movers News & Commentary MCX / NCDEX Holidays
Mutual Funds About Nirmal Bang Niveshalaya Why Associate with Nirmal Bang Mutual Fund Login Mutual Fund Register FAQs Mutual Fund Holidays SIP Calculator Mutual Funds Updates Mutual Funds Trends Mutual Fund Reports Annual Return 2018 Annual Return 2017 Mutual Fund Terms & Conditions Mutual Privacy Policy
Nirmal Bang Research Technical Calls Equity Reports Commodity Reports Currency Research Institutional Research
Nirmal Bang Media Knowledge Center Blog Support Center Become A Partner Beyond Market Careers Sitemap
Other Links Disclaimer Privacy Policy Terms Of Use Rules & Regulations Disclosures Grievances SEBI ScoresRMS Policy
Connect with Us
ATTENTION INVESTORS Depository IPO KYC
Inactive account treatmentNBSPL Policy of AMLNBEPL Policy of AMLNBCPL Policy of AMLNBSPL CSR Policy Physical Settlement Policy of Derivative Aadhar UpdationNirmalbang Privacy Policy V1.0 Documents in Vernacular Languages NBSPL Disclosure Document March 2019
Nirmal Bang Securities Pvt. Ltd. : Member NSE – ID 09391, SEBI Registration No. NSE CM Segment INZ000202536, Member NSE – ID 09391, SEBI Registration No. NSE FO Segment INZ000202536, Member NSE – ID 09391, SEBI Registration No. NSE CDS Segment INZ000202536, Member NSE Commodity – ID 09391, SEBI Registration No. NSE COMMODITY Segment Exchange Registered Broker, Member MSEI – ID 1067, SEBI Registration No. MSEI CM Segment INZ000202536, Member MSEI – ID 1067, SEBI Registration No. MSEI FO Segment INZ000202536, Member MSEI – ID 1067, SEBI Registration No. MSEI CDS Segment INZ000202536, Member MCX – ID 56460, SEBI Registration No. MCX COMMODITY Segment INZ000202536, Member NCDEX – ID 1268, SEBI Registration No. NCDEX COMMODITY Segment NZ000202536, Member ICEX – ID 2073, SEBI Registration No. ICEX COMMODITY Segment INZ000202536, Member BSE – ID 0498, SEBI Registration No. BSE CM Segment INZ000202536, Member BSE – ID 0498, SEBI Registration No. BSE FO Segment INZ000202536, Member BSE – ID 0498, SEBI Registration No. BSE CDS Segment Exchange Registered Broker, Member BSE Commodity – ID 0498, SEBI Registration No. BSE COMMODITY Segment Exchange Registered Broker, SEBI Registration No. PMS INP000002981, SEBI Registration No. Research Analyst INP000002981, SEBI Registration No. DP Participants NSDL – CDSL IN-DP-CDSL 37-99,Member Comtrack Participant Id – ID 50274, Member NERL RP Id– ID R1447, Nirmal Bang Equities Private Limited Member BSE – ID 245, SEBI Registration No. BSE CM Segment INZ000186135, Member NSE – ID 13437, SEBI Registration No. BSE CM Segment INZ000186135, Member NSE – ID 13437, SEBI Registration No. NSE FO Segment INZ000186135, Member NSE Currency – ID 13437, SEBI Registration No. NSE CDS Segment INZ000186135, Member MSEI – ID 17780, SEBI Registration No. MSEI CM Segment INZ000186135, Member MSEI – ID 17780, SEBI Registration No. MSEI FO Segment INZ000186135, SEBI Registration No. Research Analyst Segment INH000001436, Nirmal Bang Commodities Private Limited Member MCX – ID 16590, SEBI Registration No. MCX COMMODITY Segment INZ000043630, Member NCDEX – ID 00362, SEBI Registration No. NCDEX COMMODITY Segment INZ000043630, Member ICEX – ID 1165, SEBI Registration No. ICEX COMMODITY Segment INZ000043630, Member NCDEX Spot Exchange – ID 10084,Comtrack Participant CPID -5040, Participant CDSL Commodity Repository Limited - 12013300
For any grievances, please get in touch on 022-62739390 and write a mail to Contact@nirmalbang.com with Subject line as Grievances/Complain.     |    

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

AppleApp Store GooglePlay Store
AppleApp StoreGooglePlay Store
Support
Videos